Email
Print
Appetite (Eating) Disorders Market - Forecast(2024 - 2030)
Appetite (Eating) Disorders Market Overview
Appetite (Eating)
Disorders Market Size is estimated to reach $682.4 million by 2027. Furthermore,
it is poised to grow at a CAGR of 5.2% over the forecast period of 2022-2027. Appetite
(Eating) Disorders are a type of unleavened dough that is rolled flat and
sliced into long strips or strings before being expanded or extruded. Appetite
disorders are mental health disorders that involve severe problems with
thoughts about food and eating behaviors. There are various Appetite Disorders,
such as Anorexia Nervosa, Bulimia Nervosa, Rumination Disorder, Binge Eating
Disorder, Purging Disorder, Food Intake Disorder, and Others. The rise in the
prevalence of anorexia nervosa and bulimia nervosa disorders, growing research
and development activities to develop advanced treatments for appetite
disorders, and the increase in the incidences of suicides owing to psychiatric
illnesses are the major factors contributing to the growth of the Appetite
(Eating) Disorders Market for the forecast period 2022-2027.
Appetite (Eating) Disorders Market Report Coverage
The report: “Appetite
(Eating) Disorders Market Forecast (2022-2027)", by Industry ARC
covers an in-depth analysis of the following segments of the Appetite (Eating) Disorders
Market.
Key Takeaways
- Geographically, North America held a dominant market share in the year 2021, owing to the trend of healthy food. The companies are offering innovative therapies for various eating disorders. A robust economy and a growing trend in in-home care facilities are driving demand for Appetite (Eating) Disorders Market in this region.
- The increasing prevalence of psychiatric illnesses is driving the growth of the Appetite (Eating) Disorders Market. However, the lack of awareness about appetite disorders is expected to hinder the growth of the target market to a certain extent.
- A detailed analysis of strengths, weaknesses, opportunities, and threats will be provided in the Appetite (Eating) Disorders Market Report.
Appetite (Eating) Disorders Market: Market Share (%) by Region, 2021
For more details on this report - Request for Sample
Appetite (Eating) Disorders Market Segmentation Analysis- By Type
Appetite (Eating)
Disorders Market based on type can be further segmented into Anorexia Nervosa, Bulimia Nervosa, Rumination Disorder, Binge
Eating Disorder, Purging Disorder, Food Intake Disorder, and Others. Anorexia Nervosa
held a dominant market share in the year 2021. Anorexia nervosa is an eating disorder
that results in severe weight loss and patients with anorexia nervosa are
preoccupied with calorie intake and weight. The key players are focusing on
developing a quality treatment for anorexia nervosa disorders.
However, Bulimia Nervosa is estimated
to be the fastest-growing, with a CAGR of 5.8% over the forecast period of
2022-2027. This is owing to the growing prevalence of Bulimia Nervosa disorders
and the rise in the availability of treatments for Bulimia Nervosa disorders in
emerging countries.
Appetite (Eating) Disorders Market Segmentation Analysis- By End Use
Appetite (Eating)
Disorders Market based on the End-Use can be further segmented into Hospitals, Specialty Clinics, and
Others. The Hospitals segment held a dominant market
share in the year 2021. The rise in the prevalence of psychiatric illnesses
across the world and the growing availability of sophisticated professionals
for treating eating disorders in hospitals are the major factors contributing
to the growth of the Appetite (Eating) Disorders Market.
However, the Specialty Clinics segment is estimated to be the fastest-growing, with a CAGR of 6.2% over the forecast period of 2022-2027. Specialty clinics are providing outpatient clinic needs with cognitive-behavioral techniques that are specific for anorexia nervosa and bulimia nervosa disorders. As a result, the market for Appetite (Eating) Disorders is expected to grow throughout the forecast period.
Appetite (Eating) Disorders Market Segmentation Analysis- By Geography
The Appetite
(Eating) Disorders Market based on Geography can be further segmented into
North America, Europe, Asia-Pacific, South America, and the Rest of the World. North America held a dominant market share of 34% in
the year 2021. The rise in the prevalence of eating disorders is driving the
growth of the market. Key manufacturers are leading the Appetite Disorders
market in this region with innovative treatment developments and expansions.
Furthermore, Asia-Pacific is estimated to grow with the fastest CAGR over the forecast period 2022-2027. Consumers in this region have shown a willingness to spend more on their mental health. Some of the primary variables that are anticipated to enhance the demand for the Appetite (Eating) Disorders Market in this region are the growing availability of sophisticated professionals and an increase in the number of suicides owing to mental disorders.
Appetite (Eating) Disorders Market Drivers
The Increasing Prevalence of Anorexia Nervosa is a Key Factor in Market Growth.
Around 1.1% to
4.2% of the female population in the United States have bulimia nervosa and 0.5%
to 3.7% of the female population in the country are suffering from anorexia
nervosa. Approximately 1 million men and 7 million women are suffering from
appetite disorders. Women are more prone to anorexia nervosa disorders than
men. The key players are focusing on developing nutritional and functional
therapies for anorexia nervosa disorders, which is one of the major factors
driving the growth of the Appetite (Eating) Disorders Market.
The Rise in Psychiatric Illnesses is Propelling the Market Growth.
According to the
World Health Organization (WHO), around 20% of adolescents and children across
the world have mental health conditions, with suicide the second leading cause
of death among the population below 29 years old. Appetite disorders co-occur with
other psychiatric disorders, such as obsessive-compulsive disorder, mood and
anxiety disorders, and alcohol and drug abuse problems. This rise in the
prevalence of psychiatric illnesses is further propelling the growth of the Appetite
(Eating) Disorders Market.
Appetite (Eating) Disorders Market Challenges
Lack of Awareness about the Appetite Disorders is Hampering the Growth of the Appetite (Eating) Disorders Market.
According to the National Eating
Disorders Association 2020 Statistics, 60% of the patients make a full recovery
in the United States. However, only 1 in 10 people with an eating disorder are
seeking and receiving treatment for their disorders. Moreover, less than 43.6%
of the people with binge eating disorders are receiving treatment in the United
States. This lack of awareness about appetite disorders is one of the major
factors that is said to reduce the growth of the Appetite (Eating) Disorders
Market.
Appetite (Eating) Disorders Industry Outlook
Product launches,
mergers and acquisitions, joint ventures, and geographical expansions are key strategies
adopted by players in the Appetite (Eating) Disorders Market. The top 10- Appetite
(Eating) Disorders Market companies are-
- Bausch & Lomb Incorporated
- Somerset Therapeutics, LLC
- Equip
- Teva Pharmaceuticals Industries
Ltd
- Mylan N.V.
- Pfizer Inc.
- Amneal Pharmaceutical LLC
- Sun Pharmaceutical Industries
Ltd
- Moriah Behavioral Health
- Eli Lilly and Company
Recent Developments
- In April 2022, Moriah Behavioral Health opened its Dutch Valley home, which provides eating disorder treatment for adult females. It provides a comprehensive healthcare system for the treatment of anxiety disorders and eating disorders. The provides a full continuum of care for adolescent females struggling with eating disorders.
- In October 2021, Within Health company launched the first comprehensive treatment solution that is designed specifically for people suffering from various eating disorders. These solutions are designed to interrupt the progression of eating disorders and support long-term recovery. These solutions are targeted to benefit patients from receiving intensive clinical care anytime and in their homes.
- In October 2021, Equip company expanded into Colorado, Georgia, and Illinois. The expansion is targeted to ensure that every family has access to eating disorder treatment that works. The company has also closed a $13 million Series A funding round that is aimed at geographic expansion.